欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0841/002
药品名称
Quatriga Elektrolytfri
活性成分
Leucine 3.8 g
Serine 3.3 g
Proline 5.7 g
Phenylalanine 2.6 g
OLIVE OIL monohydrate 9.5 g
Methionine 2.2 g
medium-chain triglycerides 11.4 g
Lysine 3.4 g
Isoleucine 2.5 g
Histidine 1.5 g
Glycine 5.6 g
Glucose monohydrate 127.0 g
fish oil, rich in omega 3-acids 5.7 g
Arginine 6.1 g
Alanine 7.1 g
Threonine 2.2 g
Valine 3.1 g
Tyrosine 0.12 g
Tryptophan 0.63 g
SOYBEAN OIL monohydrate 11.4 g
Taurine 0.5 g
剂型
Emulsion for infusion
上市许可持有人
Fresenius Kabi AB 751 74 Uppsala Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Italy (IT)
许可日期
2009/09/01
最近更新日期
2025/01/29
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0841_002_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0841_002_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_0841_002_PAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase